JPH0684353B2 - 新規ピリジルスルホニル尿素化合物 - Google Patents

新規ピリジルスルホニル尿素化合物

Info

Publication number
JPH0684353B2
JPH0684353B2 JP5000691A JP69193A JPH0684353B2 JP H0684353 B2 JPH0684353 B2 JP H0684353B2 JP 5000691 A JP5000691 A JP 5000691A JP 69193 A JP69193 A JP 69193A JP H0684353 B2 JPH0684353 B2 JP H0684353B2
Authority
JP
Japan
Prior art keywords
formula
compound
pharmaceutically acceptable
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP5000691A
Other languages
English (en)
Japanese (ja)
Other versions
JPH061766A (ja
Inventor
マセレール ベルナル
ピロット ベルナル
シント マルク
ドゥラルジェ ジャック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of JPH061766A publication Critical patent/JPH061766A/ja
Publication of JPH0684353B2 publication Critical patent/JPH0684353B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
JP5000691A 1992-01-06 1993-01-06 新規ピリジルスルホニル尿素化合物 Expired - Lifetime JPH0684353B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9200031A FR2685917A1 (fr) 1992-01-06 1992-01-06 Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant.
FR9200031 1992-01-06

Publications (2)

Publication Number Publication Date
JPH061766A JPH061766A (ja) 1994-01-11
JPH0684353B2 true JPH0684353B2 (ja) 1994-10-26

Family

ID=9425396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5000691A Expired - Lifetime JPH0684353B2 (ja) 1992-01-06 1993-01-06 新規ピリジルスルホニル尿素化合物

Country Status (8)

Country Link
US (1) US5391559A (enExample)
EP (1) EP0551219A1 (enExample)
JP (1) JPH0684353B2 (enExample)
AU (1) AU654607B2 (enExample)
CA (1) CA2086698A1 (enExample)
FR (1) FR2685917A1 (enExample)
NZ (1) NZ245619A (enExample)
ZA (1) ZA9364B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559151A (en) * 1994-11-30 1996-09-24 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
ITMI20022749A1 (it) * 2002-12-23 2004-06-24 Cosma S P A Nuovo procedimento per la sintesi della tosemide, in particolare della forma ii pura e stabile.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
FR2659080B1 (fr) * 1990-03-02 1994-07-08 Adir Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
EP0551219A1 (fr) 1993-07-14
ZA9364B (en) 1993-08-03
US5391559A (en) 1995-02-21
FR2685917A1 (fr) 1993-07-09
AU654607B2 (en) 1994-11-10
AU3101593A (en) 1993-07-08
NZ245619A (en) 1994-10-26
JPH061766A (ja) 1994-01-11
CA2086698A1 (fr) 1993-07-07
FR2685917B1 (enExample) 1995-06-02

Similar Documents

Publication Publication Date Title
DE69730490T2 (de) Aminoheterocyclische verbindungen als antithrombotisches oder antikoagulierendes mittel
CN116751164A (zh) 蛋白酶抑制剂、其制备和用途
AU2005232159B2 (en) 2-propene-1-ones as HSP 70 inducers
JPH0466571A (ja) 脳及び心機能障害改善剤
EP3873916B1 (en) Novel dipeptide compounds and uses thereof
DE2652201A1 (de) Benzisothiazolone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
US5166162A (en) Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
JPS609506B2 (ja) 新規なｎ‐（３，４，５‐トリメトキシシンナモイル）ピペラジン誘導体の製造方法
EP1979321B9 (fr) Nouveaux composes pyridinylaminoalkylene- et pyridinyloxyalkylene- cyclopropanamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH061766A (ja) 新規ピリジルスルホニル尿素化合物
EP0847999B1 (fr) Dérivés de N-benzylpipérazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN112010774B (zh) FXIa凝血因子抑制剂、其药物组合物和用途
DE60206376T2 (de) Faktor xa inhibitor
EP2917204B1 (fr) Derives de 1h-indole-3-carboxamide et leurs utilisation comme antagonistes du p2y12
AU2006319984B2 (en) Acid addition salt of optically active dihydropyridine derivative
DE3875820T2 (de) Aromatische heterozyklische karbonsaeureamidabkoemmlinge, verfahren zur herstellung und arzneimittel, die diese enthalten.
EP1721896A1 (fr) Dérivés de phénylpyridinylpiperazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP1757586B1 (fr) Nouveaux composés 1,1-pyridinylaminocyclopropanamines polysubstitués, leur procédé de préparation et les compositions pharmaceutiques yui les contiennent
IE910684A1 (en) "New derivatives of pyridylsulfonylurea and of pyridylsulfonylthiourea process for preparing these and pharmaceutical compositions containing them"
JP3732554B2 (ja) 新規な２，３−ジヒドロベンゾフラン誘導体、その製造方法および用途
HK40094572B (en) Novel dipeptide compounds and uses thereof
HK40094572A (en) Novel dipeptide compounds and uses thereof
EP2078716A1 (fr) Nouveaux dérivés d'1H-indol-1-yl urée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
HK40060683A (en) Novel dipeptide compounds and uses thereof
HK40060683B (en) Novel dipeptide compounds and uses thereof